These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35842231)

  • 1. Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.
    Gabes M; Ragamin A; Baker A; Kann G; Donhauser T; Gabes D; Howells L; Thomas KS; Oosterhaven JAF; Pasmans SGMA; Schuttelaar ML; Apfelbacher C
    Br J Dermatol; 2022 Dec; 187(6):919-926. PubMed ID: 35842231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The German RECAP questionnaire: linguistic validation and cognitive debriefing in German adults with self-reported atopic eczema and parents of affected children.
    Gabes M; Tischer C; Herrmann A; Howells L; Apfelbacher C
    J Patient Rep Outcomes; 2021 Jan; 5(1):13. PubMed ID: 33475902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
    Howells LM; Chalmers JR; Gran S; Ahmed A; Apfelbacher C; Burton T; Howie L; Lawton S; Ridd MJ; Rogers NK; Sears AV; Spuls P; von Kobyletzki L; Thomas KS
    Br J Dermatol; 2020 Sep; 183(3):524-536. PubMed ID: 31794074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Ragamin A; Zhang J; Pasmans SGMA; Schappin R; Romeijn GLE; van Reusel MA; Oosterhaven JAF; Schuttelaar MLA
    Br J Dermatol; 2024 May; 190(6):867-875. PubMed ID: 38262143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations with Other Patient-Reported Outcome Measures.
    Onteniente-Gomis MM; Ortiz-Romero PL; Tous Romero F; Salamanca Castro AB; Ortiz de Frutos FJ
    Actas Dermosifiliogr; 2023 Jun; 114(6):488-493. PubMed ID: 36935038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [JAPANESE TRANSLATION AND LINGUISTIC VALIDATION OF THE RECAP OF ATOPIC ECZEMA (RECAP)].
    Itonaga T; Yanagida N; Nishino M; Sato S; Ohmatsu H; Otake N; Makita E; Fukuie T; Miura T; Chiyotanda M; Suzuki M; Manabe T; Koike Y; Futamura M; Nagao M; Ogata M; Takayama R; Sugiyama A; Kataoka Y; Ishiuji Y; Masuda K; Tanaka A; Nakahara T; Murota H; Saeki H; Katoh N; Ebisawa M
    Arerugi; 2023; 72(10):1240-1247. PubMed ID: 38092400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Recap of Atopic Eczema (RECAP) Measurement Instrument for Eczema Control in Adult Patients in an Asian Clinical Setting.
    Yew YW; Phuan CZY; Zhao X; Howells L; Apfelbacher CJ
    Acta Derm Venereol; 2024 May; 104():adv32323. PubMed ID: 38738773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.
    Zhang J; Ragamin A; Romeijn GLE; Loman L; Oosterhaven JAF; Schuttelaar MLA
    Br J Dermatol; 2023 Oct; 189(5):578-587. PubMed ID: 37463409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).
    Whalley D; McKenna SP; Dewar AL; Erdman RA; Kohlmann T; Niero M; Cook SA; Crickx B; Herdman MJ; Frech F; Van Assche D
    Br J Dermatol; 2004 Feb; 150(2):274-83. PubMed ID: 14996098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study.
    Gabes M; Apfelbacher C;
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):458-463. PubMed ID: 32745352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.
    Sigurdardottir G; Alsterholm M; Andersson CD; Bradley M; Sandström Falk M; Johansson EK; Lundqvist M; Sonesson A; Svensson Å; Theodosiou G; Vrang S; Von Kobyletzki LB
    Acta Derm Venereol; 2024 Jun; 104():adv38889. PubMed ID: 38898676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
    Leshem YA; Chalmers JR; Apfelbacher C; Katoh N; Gerbens LAA; Schmitt J; Spuls PI; Thomas KS; Howells L; Williams HC; Simpson EL;
    JAMA Dermatol; 2022 Dec; 158(12):1429-1435. PubMed ID: 36223090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a proxy version of the Adult social care outcome toolkit (ASCOT).
    Rand S; Caiels J; Collins G; Forder J
    Health Qual Life Outcomes; 2017 May; 15(1):108. PubMed ID: 28526055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological and educational interventions for atopic eczema in children.
    Ersser SJ; Cowdell F; Latter S; Gardiner E; Flohr C; Thompson AR; Jackson K; Farasat H; Ware F; Drury A
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD004054. PubMed ID: 24399641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement properties of patient-reported outcome measures for eczema control: a systematic review.
    Stuart BL; Howells L; Pattinson RL; Chalmers JR; Grindlay D; Rogers NK; Grinich E; Pawlitschek T; Simpson EL; Thomas KS
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1987-1993. PubMed ID: 33977561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HOME Core outcome set for clinical trials of atopic dermatitis.
    Williams HC; Schmitt J; Thomas KS; Spuls PI; Simpson EL; Apfelbacher CJ; Chalmers JR; Furue M; Katoh N; Gerbens LAA; Leshem YA; Howells L; Singh JA; Boers M;
    J Allergy Clin Immunol; 2022 Jun; 149(6):1899-1911. PubMed ID: 35351441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.
    Heinl D; Prinsen CAC; Sach T; Drucker AM; Ofenloch R; Flohr C; Apfelbacher C
    Br J Dermatol; 2017 Apr; 176(4):878-889. PubMed ID: 27543747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review.
    Heinl D; Prinsen CA; Drucker AM; Ofenloch R; Humphreys R; Sach T; Flohr C; Apfelbacher C
    Syst Rev; 2016 Feb; 5():25. PubMed ID: 26860189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.